UnitedHealth Group (NYSE:UNH) Stock Price Down 1.7% – What’s Next?

UnitedHealth Group Incorporated (NYSE:UNH)’s share price was down 1.7% during mid-day trading on Monday. The company traded as low as $408.35 and last traded at $410.8110. 4,581,055 shares changed hands during trading, a decline of 37% from the average daily volume of 7,318,698 shares. The stock had previously closed at $418.09.

Key UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Morgan Stanley raised its price target to $531 from $529 and maintained an Overweight rating. The target implies substantial potential upside from recent trading levels, reinforcing the view that UnitedHealth’s depressed valuation may not reflect its long-term earnings power. Morgan Stanley Adjusts Price Target on UnitedHealth Group
• Positive Sentiment: Zacks Research increased its FY2027 EPS estimate to $23.29 from $22.28 and its FY2028 estimate to $26.60 from $25.74. These revisions suggest analysts expect earnings growth to improve beyond the current fiscal year, potentially supporting the stock if medical-cost trends stabilize. UnitedHealth Group analyst estimates
• Neutral Sentiment: Analysts also raised their Q2 2027 EPS forecast to $6.62 from $6.35, but Zacks continues to rate UnitedHealth Hold. The combination indicates improving longer-term expectations without a strong near-term bullish consensus.
• Neutral Sentiment: UnitedHealth and Codoxo plan to present strategies for using artificial intelligence to detect healthcare fraud at an industry conference. The initiative highlights payment-integrity capabilities, but the event is unlikely to materially affect near-term revenue or earnings. Codoxo and UnitedHealth fraud detection presentation
• Negative Sentiment: Zacks trimmed its Q4 2026 EPS estimate slightly to $2.24 from $2.25. Although the reduction is minor, it underscores continuing uncertainty about near-term profitability and may be contributing to investor caution.
• Negative Sentiment: A law firm is soliciting UnitedHealth shareholders over alleged fiduciary-duty breaches. The notice contains no established finding of wrongdoing, but legal headlines can add short-term reputational and sentiment pressure. UnitedHealth shareholder legal notice

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on UNH shares. Cantor Fitzgerald raised their price target on shares of UnitedHealth Group from $440.00 to $495.00 and gave the stock an “overweight” rating in a report on Friday, July 17th. Argus upped their price objective on shares of UnitedHealth Group from $400.00 to $470.00 and gave the company a “buy” rating in a report on Monday, July 20th. Royal Bank Of Canada increased their price objective on shares of UnitedHealth Group from $478.00 to $498.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 20th. BMO Capital Markets set a $512.00 target price on UnitedHealth Group in a research note on Tuesday, July 21st. Finally, Piper Sandler boosted their target price on UnitedHealth Group from $502.00 to $504.00 and gave the company an “overweight” rating in a research report on Wednesday, October 14th. Twenty investment analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. According to MarketBeat, UnitedHealth Group currently has an average rating of “Moderate Buy” and a consensus price target of $463.93.

UnitedHealth Group Trading Down 0.9%

The business has a fifty day moving average of $389.07 and a 200-day moving average of $361.44. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.78 and a current ratio of 0.74. The company has a market capitalization of $365.15 billion, a P/E ratio of 23.23, a PEG ratio of 1.51 and a beta of 0.60.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 EPS for the quarter, beating analysts’ consensus estimates of $4.14 by $0.55. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The business had revenue of $112.70 billion during the quarter, compared to analyst estimates of $111.31 billion. During the same quarter in the previous year, the business posted $2.59 EPS. UnitedHealth Group’s quarterly revenue was down .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. Analysts anticipate that UnitedHealth Group Incorporated will post 20.62 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th were given a dividend of $2.32 per share. The ex-dividend date of this dividend was Monday, September 14th. This represents a $9.28 annualized dividend and a dividend yield of 2.3%. UnitedHealth Group’s payout ratio is presently 53.00%.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of UnitedHealth Group stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the transaction, the chief executive officer owned 15,328 shares in the company, valued at approximately $5,977,920. The trade was a 7.09% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 0.19% of the stock is owned by corporate insiders.

Institutional Trading of UnitedHealth Group

Several institutional investors and hedge funds have recently modified their holdings of the stock. BlackRock Inc. grew its holdings in UnitedHealth Group by 4.6% during the second quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate’s stock worth $31,946,594,000 after buying an additional 3,395,530 shares in the last quarter. State Street Corp lifted its stake in UnitedHealth Group by 0.7% during the 2nd quarter. State Street Corp now owns 45,633,267 shares of the healthcare conglomerate’s stock valued at $18,966,555,000 after acquiring an additional 301,081 shares in the last quarter. Bank of America Corp DE boosted its holdings in UnitedHealth Group by 21.8% during the 1st quarter. Bank of America Corp DE now owns 11,713,684 shares of the healthcare conglomerate’s stock worth $3,169,606,000 after acquiring an additional 2,097,859 shares during the last quarter. Bank of New York Mellon Corp grew its stake in shares of UnitedHealth Group by 6.1% in the 2nd quarter. Bank of New York Mellon Corp now owns 10,704,994 shares of the healthcare conglomerate’s stock worth $4,449,317,000 after acquiring an additional 616,723 shares in the last quarter. Finally, Wellington Management Group LLP grew its stake in shares of UnitedHealth Group by 5.8% in the 2nd quarter. Wellington Management Group LLP now owns 10,675,175 shares of the healthcare conglomerate’s stock worth $4,436,923,000 after acquiring an additional 583,536 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

About UnitedHealth Group

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.